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Abstract 
Introduction.Hyperglycemia in Type 2 Diabetes Mellitus (T2DM) can cause individuals to 
experience oxidative stress conditions, accompanied by a decrease in antioxidant activity in 
protecting cellular components against the attack of reactive oxygen species (ROS). ROS 
oxidized lipid components can produce Malondialdehyde (MDA). Evaluation of MDA can be 
used as a marker Oxidative stress which can indirectly describe the effects of ROS because 
ROS compounds are reactive. This study aims to determine the analysis of MDA in T2DM 
subjects at the Sentinel Public Health Center in Bengkulu City in 2017. 
Methods.Research Analytic with a case control study design in 40 samples of T2DM subjects 
(cases) and 40 Non-DM samples (control) were carried out at the Sentinel DM Health Center 
in Bengkulu City. Data collection used questionnaires, measurements of Body Mass Index, 
examination of Fasting Blood Glucose and plasma MDA (spectrophotometry).  
Results.The results of this study there were differences in characteristics (Gender, Age, BMI, 
Blood Pressure, Fasting Blood Glucose) in subjects with T2DM and Non-T2DM in the 
Bengkulu City Sentinel Health Center in 2017 (p <0,000). There was a significant difference 
(p= 0,000) in higher MDA levels in patients with T2DM than non-DM subjects. The MDA 
frequency distribution in the case was MDNormal (24%) and MDA Normal (6%), whereas in 
the control was MDA Not Normal (26%) and MDA Normal (44%). There were significant 
differences in MDA frequency distribution between cases and controls (p= 0,000). The 
subjects of T2DM had a risk of 6.77 times an increase in MDA levels compared to Non-
DMT2 (p= 0.000, OR 6.77 IK 95% 2.44-18.73). The correlation between levels of GDP and 
MDA was statistically significant (p <0.001) with a positive correlation direction (0.340).  
Conclusion.The results of this study are expected to be used as a basis for the development 
of individual therapy in subjects with T2DM in order to prevent the occurrence of 
complications early on. 
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Introduction 
Diabetes as a chronic disease that requires multifactorial risk reduction strategies. The 
increasing incidence of type 2 diabetes mellitus (T2DM) is a metabolic disease characterized 
by hyperglycemia due to damage to insulin secretion, insulin action and / or both.1 Estimates 
of DM patients in 2035 show that there are 347 million people living in urban areas and 
around 145 million people living in rural areas.2 Without effective management and 
prevention programs, the prevalence and complications of DM will continue to increase in 
the world. DM complications are associated with long-term damage, dysfunction and 
disturbances in the organ systems which are initiated by blood vessel damage which is 
characterized by an increased risk of macrovascular and microvascular complications.3,4 
Type 2 diabetes mellitus (T2DM) with the highest prevalence of around 90-95% of all 
DM cases, is a metabolic disease characterized by chronic hyperglycemia and abnormal 
metabolism of carbohydrates, proteins and lipids due to disorders of insulin secretion, insulin 
action, or both, which contribute to oxidative stress and inflammatory processes.5-7 
Hyperglycemia causes oxidative stress in T2DM through several mechanisms, including 
glucose autoxidation, nonenzymatic protein replication, polyol pathway activation, glycolysis 
pathway and pentose phosphate pathway.8-11 Oxidative stress occurs due to decreased 
concentration or antioxidant activity and increased production of free radicals reactive 
oxygen species.12  
Reactive oxygen species (ROS) are highly reactive and have a long life span so they 
can attack, modify and damage all cellular biomolecules, including deoxyribonucleic acid 
(DNA), ribonucleic acid (RNA), carbohydrates, proteins, and membrane lipids.13,14 These 
biomolecular products oxidized by ROS are often used as markers to detect oxidative stress 
activity in cells. The interaction of ROS with membrane lipids causes and increases lipid 
peroxidation which results in the formation of aldehydes with reactive terminal carbonyl 
groups such as acrolein, and malondialdehyde (MDA).15,16 Increased MDA concentrations 
are reported with increasing plasma glucose levels and duration of suffering from DM, as 
well as in inflammatory conditions.17,18 Increased MDA levels can alter the integrity of the 
cell membrane structure, trigger cell damage, and cause the release of proinflammatory 
mediators.19,20 This is because MDA can modify or denaturate several functional groups of 
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protein and DNA, which are the initial stages of inflammation mediated by oxidative 
stress.21,22  
 
 
 
 
Methods 
This study used a case-control study design with a case-control study design involving 
as many as 100 samples from the Sentinel DMT2 Health Center, which were collected 
according to the inclusion and exclusion criteria to be determined as the subject of the study, 
especially based on the results of screening of fasting blood glucose levels (GDP) , so that the 
control group (GDP <126 mg / dL) was obtained, amounting to 50 healthy subjects with no 
history of DM (non-DM) and case groups (GDP ≥ 126 mg / dL) consisting of 50 T2DM 
subjects.   
GDP levels were analyzed by spectrophotometry method of glucose oxydase-p-amino 
phenazone (GOD-PAP) and the level of lipid peroxidation was determined by examination of 
malondialdehyde (MDA) using a modifiedmethod thiobarbituric acid reactive substances 
(TBARS). The working principle of this method is based on Knoevenagel type condensation 
reaction, namely the reaction of one MDA molecule with 2 molecules of 2-tiobarbiturate acid 
under acidic conditions (low pH) and high temperature, which will release 2 water molecules 
with the formation of MDA-complex (TBA) as a pink chromophore called thiobarbituric 
acid reactive substances (TBARS), which was measured at a maximum absorbance of 532 
nm using a spectrophotometer.  
 
Results 
Table 1 shows the characteristics of cases and controls. Characteristics of the study 
subjects were tabulated into three characteristics, namely variables (including gender, age, 
BMI, blood pressure and GDP), control group (non-DM) and T2DM group, while the data 
values of each characteristic were presented in categorical form (number and percentage ) 
and continuous form (median, minimum-maximum andvalue p). 
Table 1. Characteristics of Research Subjects 
 
Variables 
Group  
Value  p Control (n = 50) Cases (n = 50) 
gender     
Male(%) 4 (8.0%) 14 (28.0%) - 
Female (%) 46 (92.0%) 36 (72.0%) - 
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Age (years)* 48 (26-77) 53 (17-78) 0,000* 
Weight (kg) 53 (42-67) 62 (50-84)  
Height (m) 1.53 (1.41-1.68) 1.55 (1.47-1.67)  
BMI (kg / m2) 23.14 (18.67-24.78) 25 48 (19.95-36.36) 0,000* 
blood    
Systolicpressure 
(mmHg) 
115 (90-140) 120 (100-160) 0,000* 
Diastolic (mmHg)* 80 (60-80) 80 (70-110) 0,000* 
GDP (mg / dL)* 99 (62-118) 190 (109-465) 0,000* 
Data is reported as a number (%) and median (minimum-maximum), data taken from the normality test using the Shapiro-
Wilk test after transformation data, data is still not normal, *Mann-Whitney test, p value <0.05: different meaningful. BMI: 
body mass index. GDP: fasting blood glucose. 
 
Observation of plasma MDA levels between groups aims to see differences in the 
status of oxidative stress in the body of each group under conditions of hyperglycemia. MDA 
levels were measured using themethod thiobarbituric acid reactive substances (TBARS), 
which was analyzed statistically using the Mann-Whitney test. MDA levels were found to be 
higher in the case group (DMT2) than in the control group (Non-DM). When compared to 
MDA levels between control subjects and T2DM patients, statistically significant differences 
were obtained (value p > 0.00). Comparison of MDA levels of the two groups can be seen in 
Table 2. 
 
Table 2. Differences in the levels of MDA (mol / L) between 
 
                           Group 
Median 
(minimum-maximum) 
 
value p 
 
MDA (mol / L) 
 
Controls (n = 50) 
Type 2 diabetes (n = 
50) 
 
1,69 (41-4,16) 
2,4 (52-43,43) 
 
   0,000* 
 
*Mann-Whitney Test 
Frequency distribution of MDA levels in cases was MDA Normal (24%) and Normal 
MDA (6%), whereas in controls the MDA was Normal (26%) and MDA Normal (44%) . 
There were significant differences in MDA frequency distribution between cases and controls 
(p= 0,000).test results Odds ratio to determine the risk of abnormal MDA levels showed 
significant differences between cases and controls (p= 0,000, OR 6.77 95% CI 2.44-18.73). 
The value of obtained Significancy 0.001 is which shows that the correlation between the 
levels of GDP and MDA in this study is statistically significant.correlation value Spearman 
of 0.340 indicates that the direction of positive correlation with the strength of weak 
correlation. Table. 3 presents the results of thecorrelation analysis Spearman. The table 
consists of the correlation coefficient (r), p value, number of subjects. 
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Table 3. Spearman CorrelationTest Results 
Variable GDP  
MDA  r 0.340 
 p 0.001 
 n 100 
    *Spearman correlation test 
 
 
Discussion 
  Hyperglycemia in T2DM can cause individuals to experience oxidative stress due to 
an increase in free radicals of reactive oxygen species (ROS) produced through glucose 
autoxidation pathways, nonenzymatic glycation of proteins, polyol pathways, glycolysis 
pathways and pentose phosphate pathways, accompanied by decreased antioxidant activity in 
protecting cellular components against ROS attacks.23-25 
Epidemiological studies and experiments show that an increase in ROS has 
implications for lipid peroxidation.26 ROS compounds cause oxidative damage by attacking 
two or more double bonds of membrane lipid components to complement electrons.27-29 In 
the propagation stage, ROS oxidized lipid components can produce malondialdehyde 
(MDA).30 ROS compounds are reactive so their measurements are very difficult to apply 
directly.31 Therefore, checking MDA levels can be used as a marker Oxidative stress that can 
indirectly describe the effects of ROS. 
The results showed that MDA levels were higher in T2DM patients compared to the 
control group and had a risk of 6.77 times an increase in MDA in the event of hypeglycemia 
in patients with T2DM (p= 0.000, OR 6.77 CI 95% 2.44-18.73) . Increased MDA levels 
indicate oxidative stress caused by increased ROS activity which causes peroxidation in the 
cellular membrane lipid components. Research on MDA examination in patients with T2DM 
has been done, especially in some countries that have the highest prevalence of diabetes, 
namely (1) China, Chen et al. (2012) found DMT2 serum MDA levels (3.69 ± 0.39 µmol / L) 
higher than controls (2.87 ± 0.63 µmol / L) with p <0.01; (2) India, Khemka et al. (2014) 
found serum MDA levels were significantly higher in non-obese T2DM (3.21 ± 1.84 nmol / 
L) than controls (2.05 ± 0.99 nmol / L) with p <0.0001; (3) Mexico, Jimenez-Osorio et al. 
(2014) obtained plasma MDA levels of T2DM patients without controlled glucose (3.5 ± 1.5 
µM) higher than those with controlled glucose control (3.07 ± 1.5 µM) with p <0.05.32-34  
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The difference in MDA concentrations reported in various results of the study was 
due to the influence of several factors. Some of these factors are the inclusion and exclusion 
criteria set by each researcher, the use of research methods and the results of examinations 
expressed for MDA examination are also different, accompanied by the geographical, socio-
economic and ethnic locations of each country that influence the subject's lifestyle.  
In this study shows the correlation between the level of GDP and MDA is statistically 
significant with the direction of positive correlation. This is the same as the opinion of Farhan 
(2015) that MDA and hyperglycemia is a relationship that describes the progression of the 
disease and the development of chronic complications in DM based on the correlation 
between MDA levels and fasting glucose. This is because MDA plays an active role in the 
onset or progression of atherosclerosis related to abnormalities of lipid metabolism, so 
regulation of blood glucose is a very important factor to reduce or prevent the formation of 
lipid peroxidation in T2DM patients which may delay the progression of DM 
complications.35 
Epidemiological studies and experiments show that an increase in ROS has 
implications for lipid peroxidation, which causes MDA accumulation to increase, and can be 
exacerbated by a decrease in the efficiency of antioxidant defense mechanisms in DM. 
Therefore, MDA levels are reported to be significantly increased in T2DM patients, and are 
among the oxidants known to be associated with T2DM complications.36 
ROS reactions with polyunsaturated fatty acids (PUFA) from the membrane lipid 
component produce several aldehyde formations, including MDA. Malondialdehyde is a 
membrane lipid degradation product that is used as a marker of lipid peroxidation in T2DM. 
T2DM is also known to be one of the diseases associated with inflammatory conditions. 
Inflammatory signal activation is characterized by increased synthesis of TNF-α, IL-1, and 
IL-6, collectively called proinflammatory cytokines. Cytokines are produced through the 
JOS, NFKB, and PKC pathways mediated by ROS and the MDA effect. MDA levels in 
serum, plasma or saliva are also reported to be associated with several diseases and 
pathologies including inflammatory conditions through the generation of ROS.37 
The imbalance ratio between increased production of ROS levels and disruption of 
antioxidant defense system activity is known to cause oxidative stress in individuals with 
DMT2 due to hyperglycemia. Oxidative stress causes inflammation via other pathways 
involving the activation of mediators of c-jun N-terminal kinase (JNK), nuclearfactor-κB 
(NF-κB), and protein kinase C (PKC), which then trigger or worsen insulin resistance and 
lead damage and apoptosiscells β of pancreatic. ROS exposure to this mediator causes 
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activation and increased expression of proinflammatory cytokines (IL-6) which are increased 
in T2DM patients. Increased Malondealdehyde (MDA) production also has the potential to 
activate CCP which is involved in the release of proinflammatory cytokines. Increased 
proinflammatory cytokines stimulate the synthesis of acute phase proteins in the liver, 
including C-Reactive Protein (CRP), α-1-antitrypsin, haptoglobin, and fibrinogen. 
Inflammation is the body's defense mechanism from danger and repairs damage and 
disturbances caused by the danger. Patients with T2DM are very closely related to 
complications that result in inflammation or inflammation.38-40 
 
 
 
Conclusion 
From the results of the study it can be concluded that Malondialdehyde in T2DM 
subjects as Oxidative Stress Markers in Bengkulu with a risk of 6.77 times an increase in 
MDA levels compared to Non-T2DM subjects. 
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